7 Results for "

Oral controlled release

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "Oral controlled release" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-100375
CAS No.: 1577222-14-0
Purity:  99.90%
Synonyms: ALKS 8700; BIIB098
Target:  

Keap1-Nrf2

Research Areas:  

Inflammation/Immunology

Diroximel fumarate (ALKS 8700) is an orally-active and well-tolerated monomethyl fumarate (MMF) proagent in a controlled-release formulation. Diroximel fumarate is considered as active equivalent to its active metabolite dimethyl fumarate (DMF). Diroximel fumarate has a favorable safety and efficacy profile, has the potential for the study of multiple sclerosis (MS). Diroximel fumarate is a Nrf2 activator that alleviate MGO-induced pain hypersensitivity .
loading...
    loading...
Cat. No.: HY-42990
CAS No.: 97281-48-6
Synonyms: HSPC; Hydrogenated soybean phosphatidylcholine
Hydrogenated soya phosphatidylcholine (hydrogenated soybean phosphatidylcholine) is a natural product. Hydrogenated soya phosphatidylcholine can extend drug release in regard to drug loading and solubility for oral drug delivery of watersoluble drugs .
loading...
    loading...
Cat. No.: HY-106539
CAS No.: 182815-44-7
Purity:  ≥95.0%
Colesevelam hydrochloride is an orally active bile acid sequestrant, lipid-lowering agent, and glycemic control agent. Colesevelam hydrochloride binds bile acids in the gastrointestinal tract to form nonabsorbable complexes, interrupts enterohepatic recirculation and increases fecal bile acid elimination. Colesevelam hydrochloride modulates FXR, TGR5, and Cyp7a1 activity and triggers cAMP signaling and GLP-1 release. Colesevelam hydrochloride alters hepatic lipid and glucose metabolism, suppresses hepatic glycogenolysis, reduces hepatic triglyceride and cholesterol levels, and increases LDL-C (low-density lipoprotein cholesterol) clearance. Colesevelam hydrochloride can be used for the research of type 2 diabetes mellitus, hypercholesterolemia, and alcohol-related liver disease .
loading...
    loading...
Cat. No.: HY-W129513
CAS No.: 26266-57-9
Research Areas:  

Others

Sorbitan monopalmitate is a food-grade, non-ionic emulsifier that exhibits oral activity. Sorbitan monopalmitate functions as a crystallization modifier, promoting the aggregation of spherical mango butter crystals, introducing lattice defects, and regulating the crystallization rate of mango butter. Sorbitan monopalmitate serves as a component of precursor vesicle gels, enabling the controlled and sustained release of drugs and facilitating the preparation of stable transdermal delivery formulations .
loading...
    loading...
Cat. No.: HY-172299
CAS No.: 13698-49-2
Target:  

Melanocortin Receptor

Research Areas:  

Endocrinology

Delmadinone acetate is an orally active compound that can control estrus and ovulation in female and male pets. Delmadinone acetate causes adrenal suppression from inhibition of release of ACTH from the pituitary gland .
loading...
    loading...
Cat. No.: HY-W721612
CAS No.: 5711-40-0
Target:  

Drug Metabolite

Research Areas:  

Cancer

Bromobric acid is a derivative of bromoacrylic acid with cytostatic and antineoplastic activity that can form ionic complexes with glucosamine to achieve controlled-release oral administration
loading...
    loading...
Cat. No.: HY-100375R
CAS No.: 1577222-14-0
Synonyms: ALKS 8700 (Standard); BIIB098 (Standard)
Research Areas:  

Inflammation/Immunology

Diroximel fumarate (Standard) is the analytical standard of Diroximel fumarate (HY-100375). This product is intended for research and analytical applications. Diroximel fumarate (ALKS 8700) is an orally-active and well-tolerated monomethyl fumarate (MMF) proagent in a controlled-release formulation. Diroximel fumarate is considered as active equivalent to its active metabolite dimethyl fumarate (DMF). Diroximel fumarate has a favorable safety and efficacy profile, has the potential for the study of multiple sclerosis (MS). Diroximel fumarate is a Nrf2 activator that alleviate MGO-induced pain hypersensitivity .
loading...
    loading...